Is ALAB a good stock to buy?
Astera Labs, Inc. Common Stock · end-of-day data as of Nov 13, 2026
- PT$345.83 +55.9%
- ConsensusBuy · 27
- P/E vs own-40.3%
- Trendbullish
- MACD0.02
- Earnings in88d
- P/E88.0x
- RSI40
- Support-3.4%
- Resistance+14.0%
- Off 52w high-55.6%
- Volume0.8x
- Bollingerlower half
- News0.00
- FCF yield+0.9%
- Sector→ -15.8%
- 52w range$98–$499
- ATR+10.9%
- Off ATH-55.6%
- P/E vs sector+199.2%
- Insiders-$126M
- MAs0 of 4
- MA20×50Death 10d ago
Updates with the 15-min delayed price. Not a forecast or investment advice.
Is Astera Labs a good stock to buy?
Astera Labs is strong on 4 of the 5 questions about the business. Astera Labs's P/E ratio is 88.0 (Nov 13, 2026). pretickt does not say whether to buy or sell.
- Demand growing
- Advantage hard to copy
- Economics very profitable
- Execution delivers
- Fragility some risks
- Price like its peers
ALAB sales growth revenue growth
+120%a year, for the last 3 yearsAstera Labs' sales grew 120% a year for 3 years, to $853M in fiscal 2025.
ALAB return on capital ROIC
pretickt analysis22%earned before tax on the money invested in it
Astera Labs earned 22% before tax on the capital invested in it in the 12 months to Sep 30, 2026; Teradyne 48%, ON Semiconductor 10%, Microchip Technology 10% and Qnity Electronics 8%.
ALAB margin on each sale gross margin
74%left after making the productAstera Labs kept 74% of each sale after making the product in the 12 months to Sep 30, 2026; its competitors' median is 49%.
ALAB margin after costs profit margin
26%of sales left after running the businessAstera Labs' operating margin was 26% in the 12 months to Sep 30, 2026, against -75% in fiscal 2022.
ALAB cash generated free cash flow
$345Mcash left after investing, last 12 monthsAstera Labs generated $345M of free cash flow in the 12 months to Sep 30, 2026, less than its reported profit.
ALAB earnings vs estimates
8 of 8quarters above the analysts' estimateAstera Labs beat the analysts' profit estimate in each of its last 8 quarters, the latest on Nov 3, 2026.
ALAB insider selling
-$785Msold, net, by its executives in 12 monthsAstera Labs' executives and directors sold a net $785M of shares in the 12 months to Nov 13, 2026; none bought.
ALAB number of employees
+72%more people in a yearAstera Labs had 756 employees at the end of fiscal 2025, 72% more than a year before.
ALAB CEO pay
$2.22Mfor fiscal 2025, 0% of it in stock and optionsAstera Labs paid its CEO $2.22M for fiscal 2025, 0% of it in stock and options.
ALAB financial health Altman Z-score
79.7Altman Z-score, safe above 3Astera Labs' Altman Z-score is 79.7 (Nov 13, 2026), above 3, where the safe zone starts.
ALAB quality checks Piotroski score
5 of 9checks passedAstera Labs passes 5 of the 9 Piotroski checks in the 12 months to Sep 30, 2026; it misses on cash against profit, the current ratio, new shares and gross margin.
ALAB biggest customers
84%of sales from its 5 biggest customersFive customers, unnamed in Astera Labs' 10-K, made 84% of its sales in fiscal 2025.
ALAB price vs profit P/E ratio
88.0×a year's earningsAstera Labs' P/E ratio is 88.0 (Nov 13, 2026).
ALAB price vs competitors
pretickt analysis88.0×a year's earnings, against its competitorsInvestors pay 88.0 times Astera Labs' earnings (Nov 13, 2026), more than for Qnity Electronics (44.5), ON Semiconductor (41.3) and Teradyne (28.7), less than for Microchip Technology (95.8).
ALAB analysts' target price target
+56%to their average targetAnalysts' average price target for Astera Labs is $346, 56% above the Nov 13, 2026 close of $221.83.
ALAB analyst ratings, 90 days
pretickt analysisNorthland Capital Marketsupgrade
In the 90 days to Nov 13, 2026, Northland Capital Markets upgraded Astera Labs.
ALAB growth priced in fair value
pretickt analysis+31%a year, for ten years, to be worth the priceAt $221.83 a share, Astera Labs' free cash flow must grow about 31% a year for ten years to be worth the price (Nov 13, 2026).
What is Astera Labs' P/E ratio?
Astera Labs' P/E ratio is 88.0 (Nov 13, 2026). Investors pay 88.0 times Astera Labs' earnings (Nov 13, 2026), more than for Qnity Electronics (44.5), ON Semiconductor (41.3) and Teradyne (28.7), less than for Microchip Technology (95.8).
Who are Astera Labs' biggest competitors?
pretickt compares Astera Labs with Teradyne, Microchip Technology, ON Semiconductor and Qnity Electronics. Astera Labs' sales grew 115% in the 12 months to Sep 30, 2026, faster than Teradyne (+75%), Microchip Technology (+33%) and ON Semiconductor (+3%).
Is Astera Labs profitable?
Astera Labs' operating margin was 26% in the 12 months to Sep 30, 2026, against -75% in fiscal 2022. Astera Labs generated $345M of free cash flow in the 12 months to Sep 30, 2026, less than its reported profit.
Who is dumping Astera Labs stock?
Astera Labs' executives and directors sold a net $785M of shares in the 12 months to Nov 13, 2026; none bought.
Who owns Astera Labs stock?
1,070 institutions hold 75% of Astera Labs' shares (Jun 30, 2026); Vanguard and BlackRock added shares that quarter, Fidelity sold some.
How many employees does Astera Labs have?
Astera Labs had 756 employees at the end of fiscal 2025, 72% more than a year before.
Who are Astera Labs' biggest customers?
Five customers, unnamed in Astera Labs' 10-K, made 84% of its sales in fiscal 2025.
From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.